MedTrace Logo

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

NCT01363466 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2011-06-01

No results posted yet for this study

Summary

GYNECO 02 hypothesis is that hysterectomy reduces the possibility of local or loco-regional relapse, especially in patient with a reduced metastatic risk and who received a local chemoradiation therapy with an increase of radiotherapy doses (45 grays).

Conditions

  • Stage IB2 Cervical Cancer
  • Stage II Cervical Cancer
  • Adenocarcinoma
  • Squamous Cell Carcinoma
  • Adenosquamous Carcinoma

Interventions

PROCEDURE

hysterectomy

Sponsors & Collaborators

  • UNICANCER

    lead OTHER

Principal Investigators

  • Philippe MORICE, Pr · Gustave Roussy, Cancer Campus, Grand Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Completion
2006-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01363466 on ClinicalTrials.gov